Captrust Financial Advisors Vista Gen Therapeutics, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.12 - $0.3 $13,102 - $32,757	109,190 New	109,190 $13,000
Q3 2022 Nov 16, 2022	BUY	$0.14 - $4.8 $14,000 - $480,000	100,000 Added 2000.0%	105,000 $16,000
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $9,422 - $17,273	-8,265 Reduced 62.31%	5,000 $6,000
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $13,216 - $21,842	7,914 Added 147.9%	13,265 $26,000
Q3 2021 Nov 16, 2021	BUY	$2.62 - $3.45 $919 - $1,210	351 Added 7.02%	5,351 $15,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $9,800 - $15,750	5,000 New	5,000 $16,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $534M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.